Peripheral/Endo

Humacyte Announces Six Presentations Scheduled for the Upcoming 52nd Annual Symposium on Vascular and Endovascular Issues, Techniques and Horizons (VEITHsymposium)

Peripheral/Endo by 0 comments

DURHAM, N.C., Nov. 13, 2025 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced the details of six presentations on the Company’s acellular tissue engineered vessel (ATEV™) that are scheduled for the 52nd Annual Symposium on Vascular and Endovascular Issues, Techniques And Horizons (VEITHsymposium), to be held November 18-22, 2025 in New York, NY. The VEITHsymposium is a premier educational event for vascular surgeons, interventional radiologists, interventional cardiologists, and other vascular specialists.

Continue Reading →

GORE ANNOUNCES POSITIVE CLINICAL TRIAL RESULTS OF THE INVESTIGATIONAL GORE® VIABAHN® FORTEGRA VENOUS STENT FOR TREATMENT OF PATIENTS WITH DEEP VENOUS ILIOCAVAL OBSTRUCTION

Peripheral/Endo by 0 comments

The investigational device evaluated in the trial, previously known as the GORE® VIAFORT Vascular Stent, will now be referred to as the GORE® VIABAHN® FORTEGRA Venous Stent. CAUTION: Investigational device. Limited by United States law to investigational use. LAS VEGAS and FLAGSTAFF, Ariz….

Continue Reading →

Venova Medical Announces First Subjects Enrolled in VENOS-3 Pivotal IDE Study of the Velocity® Percutaneous AVF System

Peripheral/Endo Regulatory by 0 comments

The Velocity System is a next generation percutaneous AVF technology designed to reduce the need for reinterventions to achieve fistula maturation and improve hemodialysis vascular access outcomes while reducing costs. LOS GATOS, Calif., Nov. 6, 2025 /PRNewswire-PRWeb/ — Venova Medical,…

Continue Reading →

Merit Medical Releases 24-Month Efficacy Results from the Randomized Arteriovenous Fistula (AVF) Arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial

Peripheral/Endo by 0 comments

SOUTH JORDAN, Utah, Nov. 05, 2025 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced positive findings from the randomized AVF arm of the WAVE trial. These findings were presented during the Late-Breaking Clinical Trials session on Tuesday, November 4, 2025, at the Vascular Interventional Advances (VIVA)3 conference held in Las Vegas, Nevada.

Continue Reading →

AVS Announces Positive Safety and Effectiveness Data in First 95 Patients Treated in Pulse IVL IDE Study

Peripheral/Endo by 0 comments

Data from the POWER PAD II Study presented at VIVA will support FDA 510(k) submission in 2026   WALTHAM, Mass.–(BUSINESS WIRE)–Amplitude Vascular Systems (AVS), a medical device company focused on safely and effectively treating severely calcified arterial disease, presented the results of the first 95 patients treated in the POWER […]

Continue Reading →
1 2 3 4 5 … 140